31
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Clinical Interventions in Aging (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on prevention and treatment of diseases in people over 65 years of age. Sign up for email alerts here.

      36,334 Monthly downloads/views I 3.829 Impact Factor I 7.4 CiteScore I 1.83 Source Normalized Impact per Paper (SNIP) I 1.044 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Potentially Inappropriate Prescriptions in Ambulatory Elderly Patients Living in Rural Areas of Romania Using STOPP/START (Version 2) Criteria

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Rational use of medications and monitoring of prescriptions in elderly patients is important to decrease the number and duration of hospitalizations, emergency medical consultations, mortality, as well as medical costs.

          Purpose

          To identify potentially inappropriate medications (PIMs) and potential prescription omissions (PPOs), and determine their prevalence based on the Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) v2 criteria and Screening Tool to Alert doctors to Right Treatment (START) v2 criteria for patients aged >65 years.

          Methods

          This cross-sectional study was conducted in two rural counties in Romania based on electronic prescriptions for chronic conditions (EPCCs) issued from 30 days to 90 days by a specialist or general practitioner. Collected EPCCs were evaluated by an interdisciplinary team of specialists based on 26 STOPP v2 criteria and 10 START v2 criteria.

          Results

          PIM prevalence was 25.80% and PPO prevalence was 41.72% for 646 EPCCs. The mean age of patients was 75 years and the mean number of drugs per EPCC was four. The most frequently identified PIMs were treatment duration (6.65%), theophylline administration (5.72%), drug indication (4.64%), cyclo-oxygenase-2 non-steroidal anti-inflammatory drugs (1.39%), and zopiclone prescription (0.77%). Statins (24.76%), beta-blockers (8.04%), and beta-2 agonist/antimuscarinic bronchodilators (5.88%) were the most frequently identified PPOs.

          Conclusion

          PPOs were more prevalent than PIMs for elderly populations living in the two rural counties in Romania we studied. Health practitioners (family physicians, specialists, and pharmacists) should focus on prophylactic and curative considerations when prescribing agents to decrease the morbidity and mortality of elderly rural Romanian patients.

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          STOPP/START criteria for potentially inappropriate prescribing in older people: version 2

          Purpose: screening tool of older people's prescriptions (STOPP) and screening tool to alert to right treatment (START) criteria were first published in 2008. Due to an expanding therapeutics evidence base, updating of the criteria was required. Methods: we reviewed the 2008 STOPP/START criteria to add new evidence-based criteria and remove any obsolete criteria. A thorough literature review was performed to reassess the evidence base of the 2008 criteria and the proposed new criteria. Nineteen experts from 13 European countries reviewed a new draft of STOPP & START criteria including proposed new criteria. These experts were also asked to propose additional criteria they considered important to include in the revised STOPP & START criteria and to highlight any criteria from the 2008 list they considered less important or lacking an evidence base. The revised list of criteria was then validated using the Delphi consensus methodology. Results: the expert panel agreed a final list of 114 criteria after two Delphi validation rounds, i.e. 80 STOPP criteria and 34 START criteria. This represents an overall 31% increase in STOPP/START criteria compared with version 1. Several new STOPP categories were created in version 2, namely antiplatelet/anticoagulant drugs, drugs affecting, or affected by, renal function and drugs that increase anticholinergic burden; new START categories include urogenital system drugs, analgesics and vaccines. Conclusion: STOPP/START version 2 criteria have been expanded and updated for the purpose of minimizing inappropriate prescribing in older people. These criteria are based on an up-to-date literature review and consensus validation among a European panel of experts.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly

            NSAIDs, non-steroidal anti-inflammatory drugs, are one of the most commonly prescribed pain medications. It is a highly effective drug class for pain and inflammation; however, NSAIDs are known for multiple adverse effects, including gastrointestinal bleeding, cardiovascular side effects, and NSAID induced nephrotoxicity. As our society ages, it is crucial to have comprehensive knowledge of this class of medication in the elderly population. Therefore, we reviewed the pharmacodynamics and pharmacokinetics, current guidelines for NSAIDs use, adverse effect profile, and drug interaction of NSAIDs and commonly used medications in the elderly.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review.

              Potentially inappropriate prescribing (PIP) is one of the main risk factors for adverse drug events (ADEs) in older people.
                Bookmark

                Author and article information

                Journal
                Clin Interv Aging
                Clin Interv Aging
                CIA
                clinintag
                Clinical Interventions in Aging
                Dove
                1176-9092
                1178-1998
                19 March 2020
                2020
                : 15
                : 407-417
                Affiliations
                [1 ]Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [2 ]“Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [3 ]Department of Medical Semiotics, Faculty of Medicine, “Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [4 ]Discipline of Psychiatry, Department of Neurosciences, Faculty of Medicine, “Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [5 ]Clinical Pharmacy Research Group, Louvain Drug Research Institute, Université catholique de Louvain UCLouvain , Bruxelles, Belgium
                [6 ]Department of Pharmacognosy, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [7 ]Department of Statistics and Biomedical Informatics, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [8 ]Department of Cardiology VI, Faculty of Medicine, “Victor Babeş” University of Medicine and Pharmacy , Timisoara, Romania
                [9 ]Cardiovascular Diseases Institute , Timisoara, Romania
                Author notes
                Correspondence: Valentina Buda Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy , 2 Eftimie Murgu Street, Timisoara300041, Romania Tel/Fax +40-256-494-604 Email buda.valentina.oana@gmail.com
                [*]

                These authors contributed equally to this work

                Author information
                http://orcid.org/0000-0002-2792-8074
                http://orcid.org/0000-0001-9630-4727
                Article
                233270
                10.2147/CIA.S233270
                7090181
                32256055
                f2c3df2f-400d-4e4a-b2f4-0d520328b6ca
                © 2020 Buda et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 03 October 2019
                : 29 January 2020
                Page count
                Tables: 10, References: 43, Pages: 11
                Categories
                Original Research

                Health & Social care
                romanian elderly,rural zones,chronic prescriptions,stopp,start
                Health & Social care
                romanian elderly, rural zones, chronic prescriptions, stopp, start

                Comments

                Comment on this article